Suhadi A, Soejoenoes A
Department of Obstetrics and Gynecology, Regency Hospital, Wonosobo, Indonesia.
Fertil Steril. 1997 May;67(5):966-8. doi: 10.1016/s0015-0282(97)81418-5.
To evaluate the efficacy, safety, and acceptability of two monthly transcervical applications of quinacrine, 252 mg, and ibuprofen, 55.5 mg, as pellets for sterilization.
Prospective clinical study.
Family planning clinic of a referral hospital.
PATIENT(S): Two hundred normal women who requested sterilization and volunteered for this method.
INTERVENTION(S): Each woman received quinacrine, 252 mg, and ibuprofen, 55.5 mg, transcervically as pellets in the proliferative phase of two consecutive menstrual cycles from August 1992 to October 1993.
MAIN OUTCOME MEASURE(S): Life-table pregnancy failure rates and incidence of complications and side effects.
RESULT(S): The pregnancy failure rate was 2.0 per 100 women at 24 months. There were no serious complications, and side effects were transient.
CONCLUSION(S): Intrauterine insertion of quinacrine pellets is a safe and acceptably effective method of nonsurgical female sterilization.
评估每月经宫颈应用252毫克喹吖因和55.5毫克布洛芬制成的药丸进行绝育的有效性、安全性和可接受性。
前瞻性临床研究。
一家转诊医院的计划生育诊所。
200名要求绝育并自愿采用该方法的正常女性。
从1992年8月至1993年10月,每位女性在连续两个月经周期的增殖期经宫颈接受252毫克喹吖因和55.5毫克布洛芬制成的药丸。
生命表妊娠失败率以及并发症和副作用的发生率。
24个月时每100名女性的妊娠失败率为2.0。无严重并发症,副作用为一过性。
经宫腔置入喹吖因药丸是一种安全且有效性可接受的非手术女性绝育方法。